Search Results
Search for other papers by S. H. Shin in
Google Scholar
PubMed
Search for other papers by R. L. Heisler in
Google Scholar
PubMed
Search for other papers by M. S. Szabo in
Google Scholar
PubMed
ABSTRACT
Patterns of prolactin release were examined using stimulating and inhibiting agents. Primary cultured pituitary cells primed with oestrogens were used for perifusion experiments. TRH (100 nmol/l) increased the peak prolactin concentration to 360% of the basal concentration, while TRH, under inhibition by 1 nmol somatostatin/l, raised the peak prolactin concentration to 185% of the basal levels. When the somatostatin concentration was increased to 10, 100 and 1000 nmol/l, TRH still stimulated prolactin release to 128%, 121% and 140% respectively, indicating that concentrations of somatostatin of 10 nmol/l or higher did not further suppress the stimulatory effect of TRH. TRH (1 μmol/l) stimulated prolactin release under the influence of 0 (control), 1, 10, 100 and 1000 nmol dopamine/l (plus 0·1 mmol ascorbic acid/l) to 394, 394, 241, 73 and 68% of the basal concentration respectively, showing that the dopamine concentrations and peak prolactin concentrations induced by TRH have an inverse linear relationship in the range 1–100 nmol dopamine/l. The stimulatory effect of dibutyryl cyclic AMP (dbcAMP) on prolactin release was also tested. The relationship between dbcAMP and somatostatin was similar to that between TRH and somatostatin. When adenohypophyses of male rats were used for perifusion experiments, somatostatin (100 nmol/l) did not inhibit basal prolactin release from the fresh male pituitary in contrast with the primary cultured pituitary cells, but dopamine (1 μmol/l) effectively inhibited prolactin release.
In conclusion, (1) oestrogen converts the somatostatin-insensitive route into a somatostatin-sensitive route for basal prolactin release, (2) TRH-induced prolactin release passes through both somatostatin-sensitive and -insensitive routes, (3) dopamine blocks both somatostatin-sensitive and -insensitive routes and (4) cAMP activates both somatostatin-sensitive and -insensitive routes.
Journal of Endocrinology (1991) 130, 79–86
Search for other papers by G. G. MURTHY in
Google Scholar
PubMed
Search for other papers by R. R. MODESTO in
Google Scholar
PubMed
SUMMARY
The effects of luteinizing hormone releasing hormone (LH-RH) and thyrotrophin releasing hormone (TRH) on rabbit adipose tissue were studied. LH-RH increased [14C]glucose oxidation and incorporation into fatty acids and had lipolytic activity, at the same time decreasing [14C]glucose incorporation in glyceride—glycerol fractions. TRH had no significant effect on glucose oxidation or lipolysis but decreased [14C]fatty acid synthesis and [14C]glucose incorporation into glyceride—glycerol fractions.
Search for other papers by H. Rui in
Google Scholar
PubMed
Search for other papers by B. S. Welinder in
Google Scholar
PubMed
Search for other papers by K. Purvis in
Google Scholar
PubMed
Search for other papers by Ø. Dolva in
Google Scholar
PubMed
ABSTRACT
Immunoassayable TRH in human ejaculate was eluted from a gel column in a form with a molecular weight larger than that of the native peptide. With reverse-phase high-performance liquid chromatography (HPLC) the same activity co-eluted with standard TRH. Incubation of ejaculates at room temperature for 8 h was associated with a time-related increase in the total immunoassayable TRH. Analysis by HPLC of ejaculates after 12 h of incubation at room temperature indicated that, whereas the levels of the peptide co-eluting with native TRH declined with time, there was a concomitant increase in the concentration of a molecular species which also cross-reacted with the TRH antiserum, but which was more hydrophobic. The latter species is presumably identical to the tetrapeptide recently described by others and which may arise from the proteolytic degradation of secretory macromolecules. Although immunological activity was present in all six fractions of split ejaculates, the bulk of the peptide was associated with the later portions, implying a major vesicular contribution. However, secretions isolated from surgical preparations of the seminal vesicles contained undetectable levels of peptide, suggesting that the ejaculation process may represent a stimulus for its appearance in the semen. This study is further support for a local involvement of TRH in male reproductive function.
J. Endocr. (1987) 114, 329–334
Search for other papers by E. R. Kühn in
Google Scholar
PubMed
Search for other papers by A. Vanderpooten in
Google Scholar
PubMed
Search for other papers by L. M. Huybrechts in
Google Scholar
PubMed
Search for other papers by E. Decuypere in
Google Scholar
PubMed
Search for other papers by V. Darras in
Google Scholar
PubMed
Search for other papers by P. J. Sharp in
Google Scholar
PubMed
ABSTRACT
Plasma GH, tri-iodothyronine (T3), thyroxine (T4) and liver 5′-monodeiodination (5′-D) activity were measured in 18-day-old chick embryos injected with thyrotrophin-releasing hormone (TRH) and human pancreatic growth hormone releasing factor (hpGRF). Injections of 0·1 and 1 μg TRH and 1·5 μg hpGRF increased the concentration of plasma GH while injection of 15 μg hpGRF had no effect. Concentrations of plasma T3 were raised after injection of TRH or hpGRF. Injections of TRH but not of hpGRF raised the concentration of plasma T4. The increases in concentration of plasma T3 after injection of TRH or hpGRF were parallelled by increases in liver 5′-D activity. An injection of 0·25 μg T4 significantly raised the concentration of T4 in plasma but had no effect on plasma T3 or liver 5′-D activity. It is concluded that the release of chicken GH by TRH or hpGRF is responsible for the observed increases in plasma concentration of T3 and liver 5′-D activity.
J. Endocr. (1988) 118, 233–236
Search for other papers by M. Mori in
Google Scholar
PubMed
Search for other papers by I. Kobayashi in
Google Scholar
PubMed
Search for other papers by S. Kobayashi in
Google Scholar
PubMed
ABSTRACT
We have investigated the effect of TRH on the accumulation of glycosylated TSH in the rat anterior pituitary gland. Hemipituitaries from adult male rats were incubated in medium containing [3H]glucosamine in the presence of TRH. [3H]Glucosamine-labelled TSH in media and pituitaries was measured by immunoprecipitation and characterized by isoelectric focusing after affinity chromatography. Incorporation of [3H]glucosamine into immunoprecipitable TSH in the media and pituitaries increased progressively with the period of incubation. Although the release of [3H]glucosamine-labelled and unlabelled TSH into media was stimulated by the addition of TRH in a time- and dose-dependent manner, TRH administration did not alter the amounts of labelled or unlabelled TSH in the anterior pituitary lobes. The anterior pituitaries were found, by isoelectric focusing analysis, to be composed of four major component peaks of [3H]glucosamine-labelled TSH. Administration of TRH caused profound changes in the radioactivity of these components and evoked new radioactive peaks, resulting in the appearance of six components in total. The present data provide evidence that TRH significantly changes the heterogeneity of glycosylated TSH in the anterior pituitary without altering the amount of the glycosylated form.
J. Endocr. (1986) 109, 227–231
Search for other papers by K. Dakshinamurti in
Google Scholar
PubMed
Search for other papers by C. S. Paulose in
Google Scholar
PubMed
Search for other papers by J. Vriend in
Google Scholar
PubMed
ABSTRACT
Pyridoxine-deficient young rats (3 weeks old) had significantly reduced levels of pituitary TSH, serum thyroxine (T4) and tri-iodothyronine (T3) compared with pyridoxine-supplemented rats. The status of the pituitary-thyroid axis of normal, pyridoxine-supplemented and pyridoxine-deficient rats was evaluated by studying the binding parameters of [3H](3-methyl-histidine2)TRH in the pituitary of these rats. The effects of TRH and T4 injections on pituitary TSH and serum TSH, T4 and T3 of these two groups were also compared. The maximal binding of TRH receptors in the pituitary of pyridoxine-deficient rats was significantly higher than that of pyridoxine-supplemented control and normal rats, but there was no change in the binding affinity. Treatment with TRH stimulated TSH synthesis and release. It also increased serum T4 and T3 in both pyridoxine-supplemented and pyridoxine-deficient rats. Treatment with T4 decreased serum and pituitary TSH in both pyridoxine-supplemented and pyridoxine-deficient rats, compared with saline-treated rats. The increased pituitary TRH receptor content, response to TRH administration and the fact that regulation at the level of the pituitary is not affected in the pyridoxine-deficient rat indicates a hypothalamic origin for the hypothyroidism of the pyridoxine-deficient rat.
J. Endocr. (1986) 109, 345–349
Search for other papers by A Basmaciogullari in
Google Scholar
PubMed
Search for other papers by C Cras-Meneur in
Google Scholar
PubMed
Search for other papers by P Czernichow in
Google Scholar
PubMed
Search for other papers by R Scharfmann in
Google Scholar
PubMed
In rodents, the first insulin-producing cells appear in the pancreas at mid-gestation around embryonic day 11 (E11). However, on the basis of various features, such as morphology or hormonal coexpression, it is apparent that these initial insulin-expressing cells are different from those that develop after E15. In the present study, the pancreatic expression of both thyrotropin-releasing hormone (TRH) mRNA and insulin was studied during embryonic and fetal life. We report here that in the rat, while insulin mRNA is detected in the pancreas as early as E12, TRH mRNA cannot be detected before E16. At that stage and later on during fetal and early postnatal life, TRH mRNA is detected in insulin-producing cells, no signal being detected in other endocrine cell types or in exocrine tissue. It was also noted, by means of triple staining performed at E17, that the expression of TRH mRNA was restricted to insulin-expressing cells negative for glucagon, whereas the few insulin-expressing cells present at that stage, which coexpress insulin and glucagon, did not express TRH mRNA. Taken together, these data indicate that TRH is a marker of insulin-expressing cells, which develop after E15.
Search for other papers by KL Geris in
Google Scholar
PubMed
Search for other papers by LR Berghman in
Google Scholar
PubMed
Search for other papers by ER Kuhn in
Google Scholar
PubMed
Search for other papers by VM Darras in
Google Scholar
PubMed
Thyrotropin-releasing hormone (TRH) and somatostatin (SRIH) concentrations were determined by RIA during both embryonic development and posthatch growth of the chicken. Both TRH and SRIH were already detectable in hypothalami of 14-day-old embryos (E14). Towards the end of incubation, hypothalamic TRH levels increased progressively, followed by a further increase in newly hatched fowl. SRIH concentrations remained stable from E14 to E17 and doubled between E17 and E18 to a concentration which was observed up to hatching. Plasma GH levels remained low during embryonic development, ending in a steep increase at hatching. Plasma TSH levels on the other hand decreased during the last week of the incubation. During growth, TRH concentrations further increased, whereas SRIH concentrations fell progressively towards those of adult animals. Plasma TSH levels increased threefold up to adulthood; the rise in plasma GH levels during growth was followed by a drop in adults. In conclusion, the present report shows that important changes occur in the hypothalamic TRH and SRIH concentration during both embryonic development and posthatch growth of the chicken. Since TRH and SRIH control GH and TSH release in the chicken, the hypothalamic data are compared with plasma GH and TSH fluctuations.
Search for other papers by G A C van Haasteren in
Google Scholar
PubMed
Search for other papers by E Linkels in
Google Scholar
PubMed
Search for other papers by W Klootwijk in
Google Scholar
PubMed
Search for other papers by H van Toor in
Google Scholar
PubMed
Search for other papers by J M M Rondeel in
Google Scholar
PubMed
Search for other papers by A P N Themmen in
Google Scholar
PubMed
Search for other papers by F H de Jong in
Google Scholar
PubMed
Search for other papers by K Valentijn in
Google Scholar
PubMed
Search for other papers by H Vaudry in
Google Scholar
PubMed
Search for other papers by K Bauer in
Google Scholar
PubMed
Search for other papers by T J Visser in
Google Scholar
PubMed
Search for other papers by W J de Greef in
Google Scholar
PubMed
Abstract
The purpose of this study was to investigate the mechanisms involved in the reduced thyroid function in starved, young female rats. Food deprivation for 3 days reduced the hypothalamic content of prothyrotrophin-releasing hormone (proTRH) mRNA, the amount of proTRH-derived peptides (TRH and proTRH160–169) in the paraventricular nucleus, the release of proTRH-derived peptides into hypophysial portal blood and the pituitary levels of TSHβ mRNA. Plasma TSH was either not affected or slightly reduced by starvation, but food deprivation induced marked increases in plasma corticosterone and decreases in plasma thyroid hormones. Refeeding after starvation normalized these parameters. Since the molar ratio of TRH and proTRH160–169 in hypophysial portal blood was not affected by food deprivation, it seems unlikely that proTRH processing is altered by starvation. The median eminence content of pGlu-His-Pro-Gly (TRH-Gly, a presumed immediate precursor of TRH), proTRH160–169 or TRH were not affected by food deprivation. Since median eminence TRH-Gly levels were very low compared with other proTRH-derived peptides it is unlikely that α-amidation is a rate-limiting step in hypothalamic TRH synthesis.
Possible negative effects of the increased corticosterone levels during starvation on proTRH and TSH synthesis were studied in adrenalectomized rats which were treated with corticosterone in their drinking water (0·2 mg/ml). In this way, the starvation-induced increase in plasma corticosterone could be prevented. Although plasma levels of thyroid hormones remained reduced, food deprivation no longer had negative effects on hypothalamic proTRH mRNA, pituitary TSHβ mRNA and plasma TSH in starved adrenalectomized rats. Thus, high levels of corticosteroids seem to exert negative effects on the synthesis and release of proTRH and TSH. This conclusion is corroborated by the observation that TRH release into hypophysial portal blood became reduced after administration of the synthetic glucocorticosteroid dexamethasone.
On the basis of these results, it is suggested that the reduced thyroid function during starvation is due to a reduced synthesis and release of TRH and TSH. Furthermore, the reduced TRH and TSH synthesis during food deprivation are probably caused by the starvation-induced enhanced adrenal secretion of corticosterone.
Journal of Endocrinology (1995) 145, 143–153
Search for other papers by A. B. ŚLEBODZIŃSKI in
Google Scholar
PubMed
Search for other papers by A. L. C. WALLACE in
Google Scholar
PubMed
The effect of thyrotrophin releasing hormone (TRH) on thyroid and pituitary function has been investigated as a possible aid to the early selection of cattle suited to tropical conditions. Two groups of six calves were used, one a shorthorn breed (SH) adapted to temperate conditions and the other an Africander cross (AX) selected for tropical climates. The dose and time responses of serum thyroid-stimulating hormone (TSH), tri-iodothyronine (T3), thyroxine (T4) and prolactin to single, repeated or multiple doses of TRH were measured by radioimmunoassay.
Levels of T3 and T4 before injection were lower in the SH than in the AX calves. After a single injection of TRH (0·4, 1, 2·5 or 5 μg/kg live weight) the percentage increase in T3 in the AX group was significantly lower than that in the SH group. No relationship was observed between the various doses and the magnitude of the response. There was, however, a negative correlation between values of T3 before injection and the maximum T3 response. The T4 : T3 molar ratio was also significantly lowered between 2·5 and 4·5 h after injection of TRH.
Changes in prolactin but not TSH concentrations were dependent upon the breed. After TRH injection, the initial increase in prolactin concentration was the same in both breeds but in the AX group the concentration then declined to values well below the pre-injection concentrations. In the SH group the prolactin concentrations returned to pre-injection levels.
When TRH was injected on 2 successive days the T3, T4 and TSH responses were less on the second day in both breeds. The prolactin response differed between breeds in a similar manner to that following a single injection of TRH.
Repeated hourly injections of increasing amounts of TRH for 4 h resulted in maximal increases of TSH after 2 h and of prolactin after 1 h. Despite continued injection the concentration of both hormones declined.
In the AX breed T3 and T4 concentrations continued to increase for 8 h after the first TRH injection whereas in the SH group no further increase in the concentrations of these hormones occurred after the first 4 h.
It is concluded that the information obtained by measuring resting serum T3 and T4 concentrations combined with changes in T3 and prolactin concentrations after TRH injection may aid in the early selection of cattle adapted to tropical conditions.
